WuXi Biologics has completed its first scale-up to 2,000L drug substance (DS) GMP manufacturing
WuXi Biologics has announced the successful scale-up of its proprietary WuXiUI™ platform to 2,000L GMP manufacturing, marking a significant milestone in biologics production. This achievement,…